Skip to content

COMPARISON OF CHLOROPROCAINE WITH ROPIVACAINE FOR SPINAL ANAESTHESIA IN SHORT GYNAECOLOGICAL SURGERIES

COMPARISON OF INTRATHECAL CHLOROPROCAINE AND ROPIVACAINE IN SHORT GYNAECOLOGICAL PROCEDURES

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/10/021521
Enrollment
50
Registered
2019-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified Health Condition 2: Q519- Congenital malformation of uterusand cervix, unspecified Health Condition 3: N750- Cyst of Bartholins gland Health Condition 4: N86- Erosion and ectropion of cervix uteri Health Condition 5: N979- Female infertility, unspecified Health Condition 6: N889- Noninflammatory disorder of cervixuteri, unspecified Health Condition 7: N768- Other specified inflammation of vagina and vulva Health Conditi

Interventions

Intervention1: Subarachnoid block: Subarachnoid block will be given in sitting position in L3-L4 intervertebral space and block characteristics and haemodynamic variables will be recorded. Control Int

Sponsors

University College of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients belonging to ASA I and ASA II undergoing short duration gynaecological procedures lasting up to 1 hour approximately Patients with height of >150 cms and <180 cms

Exclusion criteria

Exclusion criteria: Patients with contraindication to subarachnoid block Patients allergic to drugs used in this study Patients with BMI more than 30 kg/m2 Patients on long term opioid use Patients with history of chronic pain Patients with significant pre existing severe systemic illness like cardiovascular, central nervous system and hepatorenal diseases Patients not willing to participate in the study

Design outcomes

Primary

MeasureTime frame
To compare the duration of sensory block following administration of intrathecal isobaric Chloroprocaine and isobaric RopivacaineTimepoint: 0,1,2,3,4,5,6,7,8,9,10,12,14, 16,18,20,30,40,50,60 min after subarachnoid block 0,0.5,1,1.5,2,2.5,3,3.5,4, 4.5,5hrs in postoperative period

Secondary

MeasureTime frame
Hemodynamic parametersTimepoint: 0,2,5,10,15,20,25,30,35,40,45,50,55,60 min after subarachnoid block 0,0.5,1,1.5,2,2.5,3,3.5,4, 4.5,5hrs in postoperative period;To compare the time of onset, intensity and duration of motor blockTimepoint: 0,1,2,3,4,5,6,7,8,9,10,12,14, 16,18,20,30,40,50,60 min after subarachnoid block 0,0.5,1,1.5,2,2.5,3,3.5,4, 4.5,5hrs in postoperative period;To compare the time of onset, maximum level of sensory block and duration of sensory blockadeTimepoint: 0,1,2,3,4,5,6,7,8,9,10,12,14, 16,18,20,30,40,50,60 min after subarachnoid block 0,0.5,1,1.5,2,2.5,3,3.5,4, 4.5,5hrs in postoperative period

Countries

India

Contacts

Public ContactAishwarya

University College of Medical Sciences and GTB Hospital

sujatac462@gmail.com9999051546

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026